ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Allergen Specific IgE Tests Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-34W17496
Home | Market Reports | Health| Health Conditions| Allergies
Global Allergen Specific IgE Tests Market Research Report 2024
BUY CHAPTERS

Global Allergen Specific IgE Tests Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-34W17496
Report
October 2025
Pages:161
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Phadia (Thermo Fisher Scientific)
Medwiss Analytic
EUROIMMUN
Quest Diagnostics
Eurofins Biomnis
Siemens Healthineers
LabCorp
Novartis
Omega Diagnostics
Minaris Medical America
MacroArray Diagnostics
DST
Hycor Biomedical
EverlyWell
Abionic
Diagnostic Solutions Laboratory
MosaicDX
Lifelab Testing
Hob Biotech Group
Shenzhen Biocup Biotech
Hangzhou Zheda Dixun Biological Gene Engineering
ACON Biotech

Allergen Specific IgE Tests Market

The global Allergen Specific IgE Tests market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Allergen Specific IgE Tests are diagnostic tools used to detect the presence of Immunoglobulin E (IgE) antibodies in the blood that are specific to particular allergens. These tests help to identify sensitivities or allergies to various substances such as pollen, pet dander, food, insect venom, and other environmental factors.
From a downstream perspective, Hospitals accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Allergen Specific IgE Tests leading manufacturers including Phadia (Thermo Fisher Scientific), Medwiss Analytic, Euroimmun, Quest Diagnostics, Eurofins Biomnis, Siemens Healthineers, Labcorp, Novartis, Omega Diagnostics, Minaris Medical America, etc., dominate supply; the top five capture approximately % of global revenue, with Phadia (Thermo Fisher Scientific) leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Allergen Specific IgE Tests market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Allergen Specific IgE Tests Market Report

Report Metric Details
Report Name Allergen Specific IgE Tests Market
Segment by Type
  • Quantitative
  • Semi-Quantitative
  • Qualitative
Segment by Application
  • Hospitals
  • Clinics
  • Clinical Laboratories
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Phadia (Thermo Fisher Scientific), Medwiss Analytic, Euroimmun, Quest Diagnostics, Eurofins Biomnis, Siemens Healthineers, Labcorp, Novartis, Omega Diagnostics, Minaris Medical America, MacroArray Diagnostics, DST, HYCOR Biomedical, Everlywell, Abionic, Diagnostic Solutions Laboratory, MosaicDX, Lifelab Testing, HOB Biotech Group, Shenzhen Biocup Biotech, Hangzhou Zheda Dixun Biological Gene Engineering, ACON Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Allergen Specific IgE Tests study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Allergen Specific IgE Tests Market report?

Ans: The main players in the Allergen Specific IgE Tests Market are Phadia (Thermo Fisher Scientific), Medwiss Analytic, Euroimmun, Quest Diagnostics, Eurofins Biomnis, Siemens Healthineers, Labcorp, Novartis, Omega Diagnostics, Minaris Medical America, MacroArray Diagnostics, DST, HYCOR Biomedical, Everlywell, Abionic, Diagnostic Solutions Laboratory, MosaicDX, Lifelab Testing, HOB Biotech Group, Shenzhen Biocup Biotech, Hangzhou Zheda Dixun Biological Gene Engineering, ACON Biotech

What are the Application segmentation covered in the Allergen Specific IgE Tests Market report?

Ans: The Applications covered in the Allergen Specific IgE Tests Market report are Hospitals, Clinics, Clinical Laboratories, Others

What are the Type segmentation covered in the Allergen Specific IgE Tests Market report?

Ans: The Types covered in the Allergen Specific IgE Tests Market report are Quantitative, Semi-Quantitative, Qualitative

1 Study Coverage
1.1 Introduction to Allergen Specific IgE Tests: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Allergen Specific IgE Tests Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Quantitative
1.2.3 Semi-Quantitative
1.2.4 Qualitative
1.3 Market Segmentation by Application
1.3.1 Global Allergen Specific IgE Tests Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Clinical Laboratories
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Allergen Specific IgE Tests Revenue Estimates and Forecasts 2020-2031
2.2 Global Allergen Specific IgE Tests Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Allergen Specific IgE Tests Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Allergen Specific IgE Tests Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Quantitative Market Size by Players
3.3.2 Semi-Quantitative Market Size by Players
3.3.3 Qualitative Market Size by Players
3.4 Global Allergen Specific IgE Tests Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Allergen Specific IgE Tests Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Allergen Specific IgE Tests Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Allergen Specific IgE Tests Market Size by Type (2020-2031)
6.4 North America Allergen Specific IgE Tests Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Allergen Specific IgE Tests Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Allergen Specific IgE Tests Market Size by Type (2020-2031)
7.4 Europe Allergen Specific IgE Tests Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Allergen Specific IgE Tests Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Allergen Specific IgE Tests Market Size by Type (2020-2031)
8.4 Asia-Pacific Allergen Specific IgE Tests Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Allergen Specific IgE Tests Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Allergen Specific IgE Tests Market Size by Type (2020-2031)
9.4 Central and South America Allergen Specific IgE Tests Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Allergen Specific IgE Tests Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Allergen Specific IgE Tests Market Size by Type (2020-2031)
10.4 Middle East and Africa Allergen Specific IgE Tests Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Allergen Specific IgE Tests Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Phadia (Thermo Fisher Scientific)
11.1.1 Phadia (Thermo Fisher Scientific) Corporation Information
11.1.2 Phadia (Thermo Fisher Scientific) Business Overview
11.1.3 Phadia (Thermo Fisher Scientific) Allergen Specific IgE Tests Product Features and Attributes
11.1.4 Phadia (Thermo Fisher Scientific) Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.1.5 Phadia (Thermo Fisher Scientific) Allergen Specific IgE Tests Revenue by Product in 2024
11.1.6 Phadia (Thermo Fisher Scientific) Allergen Specific IgE Tests Revenue by Application in 2024
11.1.7 Phadia (Thermo Fisher Scientific) Allergen Specific IgE Tests Revenue by Geographic Area in 2024
11.1.8 Phadia (Thermo Fisher Scientific) Allergen Specific IgE Tests SWOT Analysis
11.1.9 Phadia (Thermo Fisher Scientific) Recent Developments
11.2 Medwiss Analytic
11.2.1 Medwiss Analytic Corporation Information
11.2.2 Medwiss Analytic Business Overview
11.2.3 Medwiss Analytic Allergen Specific IgE Tests Product Features and Attributes
11.2.4 Medwiss Analytic Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.2.5 Medwiss Analytic Allergen Specific IgE Tests Revenue by Product in 2024
11.2.6 Medwiss Analytic Allergen Specific IgE Tests Revenue by Application in 2024
11.2.7 Medwiss Analytic Allergen Specific IgE Tests Revenue by Geographic Area in 2024
11.2.8 Medwiss Analytic Allergen Specific IgE Tests SWOT Analysis
11.2.9 Medwiss Analytic Recent Developments
11.3 Euroimmun
11.3.1 Euroimmun Corporation Information
11.3.2 Euroimmun Business Overview
11.3.3 Euroimmun Allergen Specific IgE Tests Product Features and Attributes
11.3.4 Euroimmun Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.3.5 Euroimmun Allergen Specific IgE Tests Revenue by Product in 2024
11.3.6 Euroimmun Allergen Specific IgE Tests Revenue by Application in 2024
11.3.7 Euroimmun Allergen Specific IgE Tests Revenue by Geographic Area in 2024
11.3.8 Euroimmun Allergen Specific IgE Tests SWOT Analysis
11.3.9 Euroimmun Recent Developments
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Corporation Information
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Allergen Specific IgE Tests Product Features and Attributes
11.4.4 Quest Diagnostics Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.4.5 Quest Diagnostics Allergen Specific IgE Tests Revenue by Product in 2024
11.4.6 Quest Diagnostics Allergen Specific IgE Tests Revenue by Application in 2024
11.4.7 Quest Diagnostics Allergen Specific IgE Tests Revenue by Geographic Area in 2024
11.4.8 Quest Diagnostics Allergen Specific IgE Tests SWOT Analysis
11.4.9 Quest Diagnostics Recent Developments
11.5 Eurofins Biomnis
11.5.1 Eurofins Biomnis Corporation Information
11.5.2 Eurofins Biomnis Business Overview
11.5.3 Eurofins Biomnis Allergen Specific IgE Tests Product Features and Attributes
11.5.4 Eurofins Biomnis Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.5.5 Eurofins Biomnis Allergen Specific IgE Tests Revenue by Product in 2024
11.5.6 Eurofins Biomnis Allergen Specific IgE Tests Revenue by Application in 2024
11.5.7 Eurofins Biomnis Allergen Specific IgE Tests Revenue by Geographic Area in 2024
11.5.8 Eurofins Biomnis Allergen Specific IgE Tests SWOT Analysis
11.5.9 Eurofins Biomnis Recent Developments
11.6 Siemens Healthineers
11.6.1 Siemens Healthineers Corporation Information
11.6.2 Siemens Healthineers Business Overview
11.6.3 Siemens Healthineers Allergen Specific IgE Tests Product Features and Attributes
11.6.4 Siemens Healthineers Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.6.5 Siemens Healthineers Recent Developments
11.7 Labcorp
11.7.1 Labcorp Corporation Information
11.7.2 Labcorp Business Overview
11.7.3 Labcorp Allergen Specific IgE Tests Product Features and Attributes
11.7.4 Labcorp Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.7.5 Labcorp Recent Developments
11.8 Novartis
11.8.1 Novartis Corporation Information
11.8.2 Novartis Business Overview
11.8.3 Novartis Allergen Specific IgE Tests Product Features and Attributes
11.8.4 Novartis Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.8.5 Novartis Recent Developments
11.9 Omega Diagnostics
11.9.1 Omega Diagnostics Corporation Information
11.9.2 Omega Diagnostics Business Overview
11.9.3 Omega Diagnostics Allergen Specific IgE Tests Product Features and Attributes
11.9.4 Omega Diagnostics Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.9.5 Omega Diagnostics Recent Developments
11.10 Minaris Medical America
11.10.1 Minaris Medical America Corporation Information
11.10.2 Minaris Medical America Business Overview
11.10.3 Minaris Medical America Allergen Specific IgE Tests Product Features and Attributes
11.10.4 Minaris Medical America Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 MacroArray Diagnostics
11.11.1 MacroArray Diagnostics Corporation Information
11.11.2 MacroArray Diagnostics Business Overview
11.11.3 MacroArray Diagnostics Allergen Specific IgE Tests Product Features and Attributes
11.11.4 MacroArray Diagnostics Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.11.5 MacroArray Diagnostics Recent Developments
11.12 DST
11.12.1 DST Corporation Information
11.12.2 DST Business Overview
11.12.3 DST Allergen Specific IgE Tests Product Features and Attributes
11.12.4 DST Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.12.5 DST Recent Developments
11.13 HYCOR Biomedical
11.13.1 HYCOR Biomedical Corporation Information
11.13.2 HYCOR Biomedical Business Overview
11.13.3 HYCOR Biomedical Allergen Specific IgE Tests Product Features and Attributes
11.13.4 HYCOR Biomedical Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.13.5 HYCOR Biomedical Recent Developments
11.14 Everlywell
11.14.1 Everlywell Corporation Information
11.14.2 Everlywell Business Overview
11.14.3 Everlywell Allergen Specific IgE Tests Product Features and Attributes
11.14.4 Everlywell Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.14.5 Everlywell Recent Developments
11.15 Abionic
11.15.1 Abionic Corporation Information
11.15.2 Abionic Business Overview
11.15.3 Abionic Allergen Specific IgE Tests Product Features and Attributes
11.15.4 Abionic Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.15.5 Abionic Recent Developments
11.16 Diagnostic Solutions Laboratory
11.16.1 Diagnostic Solutions Laboratory Corporation Information
11.16.2 Diagnostic Solutions Laboratory Business Overview
11.16.3 Diagnostic Solutions Laboratory Allergen Specific IgE Tests Product Features and Attributes
11.16.4 Diagnostic Solutions Laboratory Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.16.5 Diagnostic Solutions Laboratory Recent Developments
11.17 MosaicDX
11.17.1 MosaicDX Corporation Information
11.17.2 MosaicDX Business Overview
11.17.3 MosaicDX Allergen Specific IgE Tests Product Features and Attributes
11.17.4 MosaicDX Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.17.5 MosaicDX Recent Developments
11.18 Lifelab Testing
11.18.1 Lifelab Testing Corporation Information
11.18.2 Lifelab Testing Business Overview
11.18.3 Lifelab Testing Allergen Specific IgE Tests Product Features and Attributes
11.18.4 Lifelab Testing Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.18.5 Lifelab Testing Recent Developments
11.19 HOB Biotech Group
11.19.1 HOB Biotech Group Corporation Information
11.19.2 HOB Biotech Group Business Overview
11.19.3 HOB Biotech Group Allergen Specific IgE Tests Product Features and Attributes
11.19.4 HOB Biotech Group Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.19.5 HOB Biotech Group Recent Developments
11.20 Shenzhen Biocup Biotech
11.20.1 Shenzhen Biocup Biotech Corporation Information
11.20.2 Shenzhen Biocup Biotech Business Overview
11.20.3 Shenzhen Biocup Biotech Allergen Specific IgE Tests Product Features and Attributes
11.20.4 Shenzhen Biocup Biotech Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.20.5 Shenzhen Biocup Biotech Recent Developments
11.21 Hangzhou Zheda Dixun Biological Gene Engineering
11.21.1 Hangzhou Zheda Dixun Biological Gene Engineering Corporation Information
11.21.2 Hangzhou Zheda Dixun Biological Gene Engineering Business Overview
11.21.3 Hangzhou Zheda Dixun Biological Gene Engineering Allergen Specific IgE Tests Product Features and Attributes
11.21.4 Hangzhou Zheda Dixun Biological Gene Engineering Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.21.5 Hangzhou Zheda Dixun Biological Gene Engineering Recent Developments
11.22 ACON Biotech
11.22.1 ACON Biotech Corporation Information
11.22.2 ACON Biotech Business Overview
11.22.3 ACON Biotech Allergen Specific IgE Tests Product Features and Attributes
11.22.4 ACON Biotech Allergen Specific IgE Tests Revenue and Gross Margin (2020-2025)
11.22.5 ACON Biotech Recent Developments
12 Allergen Specific IgE TestsIndustry Chain Analysis
12.1 Allergen Specific IgE Tests Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Allergen Specific IgE Tests Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Allergen Specific IgE Tests Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Phadia (Thermo Fisher Scientific)
Medwiss Analytic
EUROIMMUN
Quest Diagnostics
Eurofins Biomnis
Siemens Healthineers
LabCorp
Novartis
Omega Diagnostics
Minaris Medical America
MacroArray Diagnostics
DST
Hycor Biomedical
EverlyWell
Abionic
Diagnostic Solutions Laboratory
MosaicDX
Lifelab Testing
Hob Biotech Group
Shenzhen Biocup Biotech
Hangzhou Zheda Dixun Biological Gene Engineering
ACON Biotech
List of Tables
 Table 1. Global Allergen Specific IgE Tests Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Allergen Specific IgE Tests Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Allergen Specific IgE Tests Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Allergen Specific IgE Tests Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Allergen Specific IgE Tests Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Allergen Specific IgE Tests Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Allergen Specific IgE Tests Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Allergen Specific IgE Tests by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergen Specific IgE Tests as of 2024)
 Table 11. Global Allergen Specific IgE Tests Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Allergen Specific IgE Tests Companies Headquarters
 Table 13. Global Allergen Specific IgE Tests Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Allergen Specific IgE Tests Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Allergen Specific IgE Tests Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Allergen Specific IgE Tests Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Allergen Specific IgE Tests Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Allergen Specific IgE Tests High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Allergen Specific IgE Tests Growth Accelerators and Market Barriers
 Table 25. North America Allergen Specific IgE Tests Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Allergen Specific IgE Tests Growth Accelerators and Market Barriers
 Table 27. Europe Allergen Specific IgE Tests Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Allergen Specific IgE Tests Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Allergen Specific IgE Tests Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Allergen Specific IgE Tests Investment Opportunities and Key Challenges
 Table 31. Central and South America Allergen Specific IgE Tests Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Allergen Specific IgE Tests Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Allergen Specific IgE Tests Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Phadia (Thermo Fisher Scientific) Corporation Information
 Table 35. Phadia (Thermo Fisher Scientific) Description and Major Businesses
 Table 36. Phadia (Thermo Fisher Scientific) Product Features and Attributes
 Table 37. Phadia (Thermo Fisher Scientific) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Phadia (Thermo Fisher Scientific) Revenue Proportion by Product in 2024
 Table 39. Phadia (Thermo Fisher Scientific) Revenue Proportion by Application in 2024
 Table 40. Phadia (Thermo Fisher Scientific) Revenue Proportion by Geographic Area in 2024
 Table 41. Phadia (Thermo Fisher Scientific) Allergen Specific IgE Tests SWOT Analysis
 Table 42. Phadia (Thermo Fisher Scientific) Recent Developments
 Table 43. Medwiss Analytic Corporation Information
 Table 44. Medwiss Analytic Description and Major Businesses
 Table 45. Medwiss Analytic Product Features and Attributes
 Table 46. Medwiss Analytic Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Medwiss Analytic Revenue Proportion by Product in 2024
 Table 48. Medwiss Analytic Revenue Proportion by Application in 2024
 Table 49. Medwiss Analytic Revenue Proportion by Geographic Area in 2024
 Table 50. Medwiss Analytic Allergen Specific IgE Tests SWOT Analysis
 Table 51. Medwiss Analytic Recent Developments
 Table 52. Euroimmun Corporation Information
 Table 53. Euroimmun Description and Major Businesses
 Table 54. Euroimmun Product Features and Attributes
 Table 55. Euroimmun Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Euroimmun Revenue Proportion by Product in 2024
 Table 57. Euroimmun Revenue Proportion by Application in 2024
 Table 58. Euroimmun Revenue Proportion by Geographic Area in 2024
 Table 59. Euroimmun Allergen Specific IgE Tests SWOT Analysis
 Table 60. Euroimmun Recent Developments
 Table 61. Quest Diagnostics Corporation Information
 Table 62. Quest Diagnostics Description and Major Businesses
 Table 63. Quest Diagnostics Product Features and Attributes
 Table 64. Quest Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Quest Diagnostics Revenue Proportion by Product in 2024
 Table 66. Quest Diagnostics Revenue Proportion by Application in 2024
 Table 67. Quest Diagnostics Revenue Proportion by Geographic Area in 2024
 Table 68. Quest Diagnostics Allergen Specific IgE Tests SWOT Analysis
 Table 69. Quest Diagnostics Recent Developments
 Table 70. Eurofins Biomnis Corporation Information
 Table 71. Eurofins Biomnis Description and Major Businesses
 Table 72. Eurofins Biomnis Product Features and Attributes
 Table 73. Eurofins Biomnis Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Eurofins Biomnis Revenue Proportion by Product in 2024
 Table 75. Eurofins Biomnis Revenue Proportion by Application in 2024
 Table 76. Eurofins Biomnis Revenue Proportion by Geographic Area in 2024
 Table 77. Eurofins Biomnis Allergen Specific IgE Tests SWOT Analysis
 Table 78. Eurofins Biomnis Recent Developments
 Table 79. Siemens Healthineers Corporation Information
 Table 80. Siemens Healthineers Description and Major Businesses
 Table 81. Siemens Healthineers Product Features and Attributes
 Table 82. Siemens Healthineers Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Siemens Healthineers Recent Developments
 Table 84. Labcorp Corporation Information
 Table 85. Labcorp Description and Major Businesses
 Table 86. Labcorp Product Features and Attributes
 Table 87. Labcorp Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Labcorp Recent Developments
 Table 89. Novartis Corporation Information
 Table 90. Novartis Description and Major Businesses
 Table 91. Novartis Product Features and Attributes
 Table 92. Novartis Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Novartis Recent Developments
 Table 94. Omega Diagnostics Corporation Information
 Table 95. Omega Diagnostics Description and Major Businesses
 Table 96. Omega Diagnostics Product Features and Attributes
 Table 97. Omega Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Omega Diagnostics Recent Developments
 Table 99. Minaris Medical America Corporation Information
 Table 100. Minaris Medical America Description and Major Businesses
 Table 101. Minaris Medical America Product Features and Attributes
 Table 102. Minaris Medical America Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Minaris Medical America Recent Developments
 Table 104. MacroArray Diagnostics Corporation Information
 Table 105. MacroArray Diagnostics Description and Major Businesses
 Table 106. MacroArray Diagnostics Product Features and Attributes
 Table 107. MacroArray Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. MacroArray Diagnostics Recent Developments
 Table 109. DST Corporation Information
 Table 110. DST Description and Major Businesses
 Table 111. DST Product Features and Attributes
 Table 112. DST Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. DST Recent Developments
 Table 114. HYCOR Biomedical Corporation Information
 Table 115. HYCOR Biomedical Description and Major Businesses
 Table 116. HYCOR Biomedical Product Features and Attributes
 Table 117. HYCOR Biomedical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. HYCOR Biomedical Recent Developments
 Table 119. Everlywell Corporation Information
 Table 120. Everlywell Description and Major Businesses
 Table 121. Everlywell Product Features and Attributes
 Table 122. Everlywell Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Everlywell Recent Developments
 Table 124. Abionic Corporation Information
 Table 125. Abionic Description and Major Businesses
 Table 126. Abionic Product Features and Attributes
 Table 127. Abionic Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. Abionic Recent Developments
 Table 129. Diagnostic Solutions Laboratory Corporation Information
 Table 130. Diagnostic Solutions Laboratory Description and Major Businesses
 Table 131. Diagnostic Solutions Laboratory Product Features and Attributes
 Table 132. Diagnostic Solutions Laboratory Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. Diagnostic Solutions Laboratory Recent Developments
 Table 134. MosaicDX Corporation Information
 Table 135. MosaicDX Description and Major Businesses
 Table 136. MosaicDX Product Features and Attributes
 Table 137. MosaicDX Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. MosaicDX Recent Developments
 Table 139. Lifelab Testing Corporation Information
 Table 140. Lifelab Testing Description and Major Businesses
 Table 141. Lifelab Testing Product Features and Attributes
 Table 142. Lifelab Testing Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. Lifelab Testing Recent Developments
 Table 144. HOB Biotech Group Corporation Information
 Table 145. HOB Biotech Group Description and Major Businesses
 Table 146. HOB Biotech Group Product Features and Attributes
 Table 147. HOB Biotech Group Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 148. HOB Biotech Group Recent Developments
 Table 149. Shenzhen Biocup Biotech Corporation Information
 Table 150. Shenzhen Biocup Biotech Description and Major Businesses
 Table 151. Shenzhen Biocup Biotech Product Features and Attributes
 Table 152. Shenzhen Biocup Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 153. Shenzhen Biocup Biotech Recent Developments
 Table 154. Hangzhou Zheda Dixun Biological Gene Engineering Corporation Information
 Table 155. Hangzhou Zheda Dixun Biological Gene Engineering Description and Major Businesses
 Table 156. Hangzhou Zheda Dixun Biological Gene Engineering Product Features and Attributes
 Table 157. Hangzhou Zheda Dixun Biological Gene Engineering Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 158. Hangzhou Zheda Dixun Biological Gene Engineering Recent Developments
 Table 159. ACON Biotech Corporation Information
 Table 160. ACON Biotech Description and Major Businesses
 Table 161. ACON Biotech Product Features and Attributes
 Table 162. ACON Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 163. ACON Biotech Recent Developments
 Table 164. Raw Materials Key Suppliers
 Table 165. Distributors List
 Table 166. Market Trends and Market Evolution
 Table 167. Market Drivers and Opportunities
 Table 168. Market Challenges, Risks, and Restraints
 Table 169. Research Programs/Design for This Report
 Table 170. Key Data Information from Secondary Sources
 Table 171. Key Data Information from Primary Sources


List of Figures
 Figure 1. Allergen Specific IgE Tests Product Picture
 Figure 2. Global Allergen Specific IgE Tests Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Quantitative Product Picture
 Figure 4. Semi-Quantitative Product Picture
 Figure 5. Qualitative Product Picture
 Figure 6. Global Allergen Specific IgE Tests Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hospitals
 Figure 8. Clinics
 Figure 9. Clinical Laboratories
 Figure 10. Others
 Figure 11. Allergen Specific IgE Tests Report Years Considered
 Figure 12. Global Allergen Specific IgE Tests Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Allergen Specific IgE Tests Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Allergen Specific IgE Tests Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Allergen Specific IgE Tests Revenue Market Share by Region (2020-2031)
 Figure 16. Global Allergen Specific IgE Tests Revenue Market Share Ranking (2024)
 Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 18. Quantitative Revenue Market Share by Player in 2024
 Figure 19. Semi-Quantitative Revenue Market Share by Player in 2024
 Figure 20. Qualitative Revenue Market Share by Player in 2024
 Figure 21. Global Allergen Specific IgE Tests Revenue Market Share by Type (2020-2031)
 Figure 22. Global Allergen Specific IgE Tests Revenue Market Share by Application (2020-2031)
 Figure 23. North America Allergen Specific IgE Tests Revenue YoY (2020-2031) & (US$ Million)
 Figure 24. North America Top 5 Players Allergen Specific IgE Tests Revenue (US$ Million) in 2024
 Figure 25. North America Allergen Specific IgE Tests Revenue (US$ Million) by Type (2020 - 2031)
 Figure 26. North America Allergen Specific IgE Tests Revenue (US$ Million) by Application (2020-2031)
 Figure 27. US Allergen Specific IgE Tests Revenue (2020-2031) & (US$ Million)
 Figure 28. Canada Allergen Specific IgE Tests Revenue (2020-2031) & (US$ Million)
 Figure 29. Mexico Allergen Specific IgE Tests Revenue (2020-2031) & (US$ Million)
 Figure 30. Europe Allergen Specific IgE Tests Revenue YoY (2020-2031) & (US$ Million)
 Figure 31. Europe Top 5 Players Allergen Specific IgE Tests Revenue (US$ Million) in 2024
 Figure 32. Europe Allergen Specific IgE Tests Revenue (US$ Million) by Type (2020-2031)
 Figure 33. Europe Allergen Specific IgE Tests Revenue (US$ Million) by Application (2020-2031)
 Figure 34. Germany Allergen Specific IgE Tests Revenue (2020-2031) & (US$ Million)
 Figure 35. France Allergen Specific IgE Tests Revenue (2020-2031) & (US$ Million)
 Figure 36. U.K. Allergen Specific IgE Tests Revenue (2020-2031) & (US$ Million)
 Figure 37. Italy Allergen Specific IgE Tests Revenue (2020-2031) & (US$ Million)
 Figure 38. Russia Allergen Specific IgE Tests Revenue (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Allergen Specific IgE Tests Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Asia-Pacific Top 8 Players Allergen Specific IgE Tests Revenue (US$ Million) in 2024
 Figure 41. Asia-Pacific Allergen Specific IgE Tests Revenue (US$ Million) by Type (2020-2031)
 Figure 42. Asia-Pacific Allergen Specific IgE Tests Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Indonesia Allergen Specific IgE Tests Revenue (2020-2031) & (US$ Million)
 Figure 44. Japan Allergen Specific IgE Tests Revenue (2020-2031) & (US$ Million)
 Figure 45. South Korea Allergen Specific IgE Tests Revenue (2020-2031) & (US$ Million)
 Figure 46. Australia Allergen Specific IgE Tests Revenue (2020-2031) & (US$ Million)
 Figure 47. India Allergen Specific IgE Tests Revenue (2020-2031) & (US$ Million)
 Figure 48. Indonesia Allergen Specific IgE Tests Revenue (2020-2031) & (US$ Million)
 Figure 49. Vietnam Allergen Specific IgE Tests Revenue (2020-2031) & (US$ Million)
 Figure 50. Malaysia Allergen Specific IgE Tests Revenue (2020-2031) & (US$ Million)
 Figure 51. Philippines Allergen Specific IgE Tests Revenue (2020-2031) & (US$ Million)
 Figure 52. Singapore Allergen Specific IgE Tests Revenue (2020-2031) & (US$ Million)
 Figure 53. Central and South America Allergen Specific IgE Tests Revenue YoY (2020-2031) & (US$ Million)
 Figure 54. Central and South America Top 5 Players Allergen Specific IgE Tests Revenue (US$ Million) in 2024
 Figure 55. Central and South America Allergen Specific IgE Tests Revenue (US$ Million) by Type (2020-2031)
 Figure 56. Central and South America Allergen Specific IgE Tests Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Brazil Allergen Specific IgE Tests Revenue (2020-2025) & (US$ Million)
 Figure 58. Argentina Allergen Specific IgE Tests Revenue (2020-2025) & (US$ Million)
 Figure 59. Middle East and Africa Allergen Specific IgE Tests Revenue YoY (2020-2031) & (US$ Million)
 Figure 60. Middle East and Africa Top 5 Players Allergen Specific IgE Tests Revenue (US$ Million) in 2024
 Figure 61. South America Allergen Specific IgE Tests Revenue (US$ Million) by Type (2020-2031)
 Figure 62. Middle East and Africa Allergen Specific IgE Tests Revenue (US$ Million) by Application (2020-2031)
 Figure 63. GCC Countries Allergen Specific IgE Tests Revenue (2020-2025) & (US$ Million)
 Figure 64. Israel Allergen Specific IgE Tests Revenue (2020-2025) & (US$ Million)
 Figure 65. Egypt Allergen Specific IgE Tests Revenue (2020-2025) & (US$ Million)
 Figure 66. South Africa Allergen Specific IgE Tests Revenue (2020-2025) & (US$ Million)
 Figure 67. Allergen Specific IgE Tests Industry Chain Mapping
 Figure 68. Channels of Distribution (Direct Vs Distribution)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Specific IgE Blood Based Allergy Testing Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-33D17671
Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Allergen Specific IgE Tests Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-34W17496
Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Eustachian Tube Dilation Balloon Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29H16441
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Type 2 Inflammation Targeting Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33T16543
Tue Sep 23 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions